Beneficial effects of the Shikoku Walking Pilgrimage on mental and physical health

Beneficial effects of the Shikoku Walking Pilgrimage on mental and physical health - Effects of walking pilgrimage on health

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012182

Enrollment

Registered

2013-11-01

Start date

2011-12-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy normal adults

Interventions

Walking Shikoku pilgrimage and worshipping at temples

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1.Healthy adults 2.Those whose informed consent can be obtained

Exclusion criteria

Exclusion criteria: 1.Those who are recognized as unsuitable to the test by medical doctor. 2.Those who cannot agree to participate in this trial.

Design outcomes

Primary

Measure	Time frame
1.Biochemical data (blood) Lipid oxidative stress marker, BDNF, GOT, GPT, gamma-GTP, HDL cholesterol, LDL cholesterol, Triglycerides, Glucose, Uric acid, Urea nitrogen, Total bilirubin acid, Cholinesterase, CK, Amylase, Cortisol, NK cell activity, Immunoglobulin (IgG, IgA, IgM) 2.Biochemical data (urine) Adrenaline, Noradrenaline, Dopamine, Creatinine 3.Biochmical data (saliva) Cortisol, sIgA 4.Physiological data Heart rate variability, body acceleration, Flicker perception frequency 5.Psychological data Profile of Mood States (POMS) One week before and after, and during intervention.	—

Measure

Time frame

1.Biochemical data (blood) Lipid oxidative stress marker, BDNF, GOT, GPT, gamma-GTP, HDL cholesterol, LDL cholesterol, Triglycerides, Glucose, Uric acid, Urea nitrogen, Total bilirubin acid, Cholinesterase, CK, Amylase, Cortisol, NK cell activity, Immunoglobulin (IgG, IgA, IgM) 2.Biochemical data (urine) Adrenaline, Noradrenaline, Dopamine, Creatinine 3.Biochmical data (saliva) Cortisol, sIgA 4.Physiological data Heart rate variability, body acceleration, Flicker perception frequency 5.Psychological data Profile of Mood States (POMS) One week before and after, and during intervention.

—

Countries

Japan

Contacts

Public ContactYasukazu Yoshida

National Institute of Advanced Industrial Science and Technology (AIST) Health Research Institute

yoshida-ya@aist.go.jp+81-87-869-4149

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026